Novavax (NVAX) EBT Margin (2010 - 2026)

Novavax's EBT Margin history runs 17 years deep, the most recent figure standing at 6.1% for Q1 2026.

• In Q1 2026, EBT Margin fell 8408.0% year-over-year to 6.1%; the TTM figure through Mar 2026 stood at 16.2% (down 5512.0% YoY), while the FY2025 annual figure was 39.36%, up 6525.0% from the prior year.
• EBT Margin was 6.1% for Q1 2026 at Novavax, down from 12.17% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 77.98% in Q1 2025 to a low of 361.6% in Q1 2023.
• Historically, EBT Margin has averaged 75.51% across 5 years, with a median of 51.63% in 2022.
• The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 32177 bps in 2022, then slumped 39088 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 51.63% in 2022, then decreased by 17 bps to 60.65% in 2023, then tumbled by 37 bps to 83.32% in 2024, then surged by 115 bps to 12.17% in 2025, then sank by 150 bps to 6.1% in 2026.
• The last three EBT Margin figures came in at 6.1% (Q1 2026), 12.17% (Q4 2025), and 288.22% (Q3 2025), per Business Quant data.